Orchestra BioMed (OBIO) News Today $5.28 +0.11 (+2.13%) (As of 11/20/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period B. Riley Equities Analysts Lift Earnings Estimates for OBIONovember 20 at 1:53 AM | americanbankingnews.comHC Wainwright Has Positive Forecast for OBIO FY2024 EarningsNovember 20 at 1:53 AM | americanbankingnews.comOrchestra BioMed (NASDAQ:OBIO) Earns Buy Rating from HC WainwrightNovember 19 at 4:25 AM | americanbankingnews.comChardan Capital Has Pessimistic View of OBIO FY2024 EarningsNovember 19 at 1:53 AM | americanbankingnews.comFY2024 EPS Estimates for Orchestra BioMed Raised by B. RileyOrchestra BioMed Holdings, Inc. (NASDAQ:OBIO - Free Report) - Stock analysts at B. Riley upped their FY2024 EPS estimates for Orchestra BioMed in a research note issued on Wednesday, November 13th. B. Riley analyst K. Bauser now forecasts that the company will post earnings of ($1.67) per share fNovember 18 at 1:49 AM | marketbeat.comResearch Analysts Offer Predictions for OBIO FY2024 EarningsOrchestra BioMed Holdings, Inc. (NASDAQ:OBIO - Free Report) - Equities researchers at Chardan Capital dropped their FY2024 EPS estimates for shares of Orchestra BioMed in a note issued to investors on Wednesday, November 13th. Chardan Capital analyst K. Nakae now expects that the company will posNovember 18 at 1:49 AM | marketbeat.comHC Wainwright Has Optimistic Outlook of OBIO FY2024 EarningsOrchestra BioMed Holdings, Inc. (NASDAQ:OBIO - Free Report) - Research analysts at HC Wainwright upped their FY2024 earnings estimates for shares of Orchestra BioMed in a report issued on Thursday, November 14th. HC Wainwright analyst Y. Chen now anticipates that the company will post earnings peNovember 18 at 1:49 AM | marketbeat.comAcutus Medical (NASDAQ:AFIB) & Orchestra BioMed (NASDAQ:OBIO) Head to Head ContrastNovember 18 at 1:33 AM | americanbankingnews.comHC Wainwright Reaffirms "Buy" Rating for Orchestra BioMed (NASDAQ:OBIO)HC Wainwright restated a "buy" rating and set a $14.00 price objective on shares of Orchestra BioMed in a research note on Friday.November 15, 2024 | marketbeat.comOrchestra BioMed’s Strong Financial Performance and Strategic Developments Reinforce Buy Rating with $14 Price TargetNovember 15, 2024 | markets.businessinsider.comOrchestra BioMed Holdings: Strategic Financial Developments and Clinical Progress Justify Buy RatingNovember 13, 2024 | markets.businessinsider.comOrchestra BioMed Reports Third Quarter 2024 Financial Results and Provides a Business UpdateNovember 12, 2024 | globenewswire.comOrchestra BioMed to Present at Jefferies London Healthcare ConferenceNovember 9, 2024 | msn.comOrchestra BioMed Holdings IncNovember 8, 2024 | morningstar.comOrchestra BioMed to Participate in Jefferies London Healthcare ConferenceNovember 7, 2024 | markets.businessinsider.comDavid P. Hochman Purchases 2,500 Shares of Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) StockSeptember 27, 2024 | insidertrades.comOrchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Director Sells $11,280.00 in StockSeptember 11, 2024 | insidertrades.comOrchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Director Eric S. Fain Sells 2,000 Shares of StockOrchestra BioMed Holdings, Inc. (NASDAQ:OBIO - Get Free Report) Director Eric S. Fain sold 2,000 shares of the company's stock in a transaction dated Friday, September 6th. The stock was sold at an average price of $5.64, for a total transaction of $11,280.00. Following the completion of the sale, the director now owns 44,810 shares in the company, valued at approximately $252,728.40. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website.September 10, 2024 | marketbeat.comInsider Selling: Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Insider Sells 6,819 Shares of StockSeptember 7, 2024 | insidertrades.comOrchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Insider Darren Sherman Sells 6,837 SharesSeptember 7, 2024 | insidertrades.comHC Wainwright & Co. Initiates Coverage of Orchestra BioMed Holdings (OBIO) with Buy RecommendationAugust 23, 2024 | msn.comHC Wainwright Begins Coverage on Orchestra BioMed (NASDAQ:OBIO)HC Wainwright started coverage on Orchestra BioMed in a report on Thursday. They issued a "buy" rating and a $14.00 price target for the company.August 22, 2024 | marketbeat.comFY2024 EPS Estimates for Orchestra BioMed Holdings, Inc. Lowered by Analyst (NASDAQ:OBIO)Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO - Free Report) - Investment analysts at Chardan Capital lowered their FY2024 EPS estimates for Orchestra BioMed in a research note issued on Tuesday, August 13th. Chardan Capital analyst K. Nakae now expects that the company will post earnings of ($1.6August 16, 2024 | marketbeat.comOrchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Insider Purchases $14,600.00 in StockAugust 16, 2024 | insidertrades.comInsider Buying: Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Insider Buys 2,500 Shares of StockOrchestra BioMed Holdings, Inc. (NASDAQ:OBIO - Get Free Report) insider David P. Hochman bought 2,500 shares of Orchestra BioMed stock in a transaction that occurred on Wednesday, August 14th. The stock was bought at an average price of $5.84 per share, for a total transaction of $14,600.00. Following the completion of the acquisition, the insider now directly owns 567,998 shares of the company's stock, valued at $3,317,108.32. The purchase was disclosed in a legal filing with the SEC, which is available at this hyperlink.August 15, 2024 | marketbeat.comMDT Aug 2024 81.000 putAugust 15, 2024 | uk.finance.yahoo.comOrchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Forecasted to Earn Q3 2024 Earnings of ($0.43) Per ShareOrchestra BioMed Holdings, Inc. (NASDAQ:OBIO - Free Report) - B. Riley dropped their Q3 2024 EPS estimates for Orchestra BioMed in a report released on Tuesday, August 13th. B. Riley analyst K. Bauser now forecasts that the company will post earnings of ($0.43) per share for the quarter, down froAugust 15, 2024 | marketbeat.comMDT Aug 2024 87.000 callAugust 15, 2024 | uk.finance.yahoo.comOrchestra BioMed Holdings Reports Second Quarter 2024 Financial Results and Business UpdatesAugust 15, 2024 | msn.comOrchestra BioMed (NASDAQ:OBIO) Issues Earnings ResultsOrchestra BioMed (NASDAQ:OBIO - Get Free Report) released its earnings results on Monday. The company reported ($0.45) EPS for the quarter, missing analysts' consensus estimates of ($0.41) by ($0.04). Orchestra BioMed had a negative net margin of 2,330.46% and a negative return on equity of 70.18%. The business had revenue of $0.78 million for the quarter, compared to the consensus estimate of $1.04 million.August 14, 2024 | marketbeat.comOrchestra BioMed Holdings, Inc.: Orchestra BioMed Reports Second Quarter 2024 Financial Results and Provides a Business UpdateAugust 14, 2024 | finanznachrichten.deBuy Rating Affirmed for Orchestra BioMed on Strong Financials and Promising BackBeat CNT DevelopmentsAugust 14, 2024 | markets.businessinsider.comOBIO Stock Earnings: Orchestra BioMed Hldgs Misses EPS, Beats Revenue for Q2 2024August 12, 2024 | msn.comOrchestra BioMed Reports Second Quarter 2024 Financial Results and Provides a Business UpdateAugust 12, 2024 | globenewswire.comOrchestra BioMed Appoints John Mack to Board of DirectorsAugust 1, 2024 | msn.comOrchestra BioMed Announces Appointment of Cardiovascular Device Industry Expert John Mack to Board of DirectorsJuly 30, 2024 | finance.yahoo.comQ2 2024 Earnings Forecast for Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Issued By B. RileyOrchestra BioMed Holdings, Inc. (NASDAQ:OBIO - Free Report) - B. Riley issued their Q2 2024 EPS estimates for shares of Orchestra BioMed in a research note issued to investors on Wednesday, July 24th. B. Riley analyst K. Bauser forecasts that the company will earn ($0.40) per share for the quarteJuly 29, 2024 | marketbeat.comOrchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Short Interest UpdateOrchestra BioMed Holdings, Inc. (NASDAQ:OBIO - Get Free Report) was the target of a large increase in short interest in the month of July. As of July 15th, there was short interest totalling 1,020,000 shares, an increase of 24.2% from the June 30th total of 821,100 shares. Based on an average trading volume of 124,400 shares, the short-interest ratio is presently 8.2 days. Approximately 5.0% of the shares of the stock are short sold.July 28, 2024 | marketbeat.comOrchestra experiment shows older people can identify and remember musical themes as well as younger peopleJuly 26, 2024 | msn.comOrchestra BioMed (NASDAQ:OBIO) Coverage Initiated at B. RileyB. Riley initiated coverage on Orchestra BioMed in a research note on Thursday. They issued a "buy" rating and a $15.00 price target on the stock.July 25, 2024 | marketbeat.comPrecision Neuroscience Expands Executive Team as Brain–Computer Interface Industry Rapidly AdvancesJuly 23, 2024 | finance.yahoo.comInsider Buying: Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Insider Purchases 4,000 Shares of StockJune 4, 2024 | insidertrades.comOrchestra BioMed to Participate in Jefferies Global Healthcare ConferenceMay 22, 2024 | globenewswire.comChardan Capital Weighs in on Orchestra BioMed Holdings, Inc.'s FY2024 Earnings (NASDAQ:OBIO)Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO - Free Report) - Equities research analysts at Chardan Capital issued their FY2024 earnings per share (EPS) estimates for Orchestra BioMed in a research report issued to clients and investors on Tuesday, May 14th. Chardan Capital analyst K. Nakae forecMay 17, 2024 | marketbeat.comOrchestra BioMed Unveils Q1 2024 Financial Results, Advances Pivotal Studies on Innovative Medical TherapiesMay 15, 2024 | msn.comOrchestra BioMed Holdings, Inc.: Orchestra BioMed Reports First Quarter 2024 Financial Results and Provides a Business UpdateMay 14, 2024 | finanznachrichten.deBuy Rating Endorsed for OBIO on Strong Financials and Promising BackBeat CNT ProspectsMay 14, 2024 | markets.businessinsider.comOBIO Stock Earnings: Orchestra BioMed Hldgs Beats EPS, Misses Revenue for Q1 2024May 13, 2024 | investorplace.comOrchestra BioMed Reports First Quarter 2024 Financial Results and Provides a Business UpdateMay 13, 2024 | globenewswire.comOrchestra BioMed Expands Global Patent Portfolio for Hypertension TherapyMay 1, 2024 | msn.com Get Orchestra BioMed News Delivered to You Automatically Sign up to receive the latest news and ratings for OBIO and its competitors with MarketBeat's FREE daily newsletter. Email Address Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners (Ad)The "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. A tax-free gift so powerful it could reshape the financial destinies of millions of IRA and 401(k) owners… Claim your FREE 2024 Gold Guide OBIO Media Mentions By Week OBIO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. OBIO News Sentiment▼0.570.46▲Average Medical News Sentiment OBIO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. OBIO Articles This Week▼201▲OBIO Articles Average Week Get Orchestra BioMed News Delivered to You Automatically Sign up to receive the latest news and ratings for OBIO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies EMBC News Today OFIX News Today IRMD News Today KIDS News Today SRDX News Today SIBN News Today TMCI News Today CATX News Today TCMD News Today RCEL News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:OBIO) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Orchestra BioMed Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Orchestra BioMed With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free OBIO Stock Alerts